Fatal Case of Rhabdomyolysis Post-COVID-19 Vaccine

Infect Drug Resist. 2021 Sep 24:14:3929-3935. doi: 10.2147/IDR.S331362. eCollection 2021.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 pandemic has taken away the lives of many people (>4 million per WHO) around the world as of July 2021. With the advancement of the vaccine against COVID-19, in less than a year since the start of the pandemic, the infection rate has come under control in certain regions but is still rising in many more. However, with time, we are also learning a lot more about the adverse events related to the vaccine. This report documents the first fatal case of rhabdomyolysis potentially associated with the COVID-19 vaccine and supports the possibility that autoimmunity is a major risk factor for covid vaccine-related rhabdomyolysis.

Keywords: COVID-19 vaccines; autoimmune disorders; rhabdomyolysis.

Publication types

  • Case Reports

Grants and funding

The author has not declared receiving any grant/funding for this research from any funding agency in the public, commercial, or not-for-profit sectors.